Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Infibeam IPO and Thyrocare Technologies IPO.
Infibeam IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Thyrocare Technologies IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Infibeam IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Elara Capital (India) Private Limited ICICI Securities Limited Kotak Mahindra Capital Company Limited SBI Capital Markets Limited |
Edelweiss Financial Services Ltd ICICI Securities Limited Jm Financial Limited |
| Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Infibeam IPO is up to ₹450.00 Cr whereas the issue size of the Thyrocare Technologies IPO is up to ₹479.21 Cr. The final issue price of Infibeam IPO is ₹432.00 per share and of Thyrocare Technologies IPO is ₹446.00 per share.
| Infibeam IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹360.00 per share | ₹420.00 per share |
| Issue Price (Upper) | ₹432.00 per share | ₹446.00 per share |
| Issue Price (Final) | ₹432.00 per share | ₹446.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 34 shares | 33 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | 1,07,44,708 shares | |
| OFS Issue Size (Amount) | ||
| Issue Size Total | 1,04,16,666 shares | 1,07,44,708 shares |
| Issue Size Total (Amount) | up to ₹450.00 Cr | up to ₹479.21 Cr |
Infibeam IPO opens on Mar 21, 2016, while Thyrocare Technologies IPO opens on Apr 27, 2016. The closing date of Infibeam IPO and Thyrocare Technologies IPO is Mar 23, 2016, and Apr 29, 2016, respectively.
| Infibeam IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 21, 2016 | Apr 27, 2016 |
| Issue Close | Mar 23, 2016 | Apr 29, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Infibeam IPO P/E ratio is , as compared to Thyrocare Technologies IPO P/E ratio of .
| Infibeam IPO | Thyrocare Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 64.96% | |||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 63.96% | |||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 17.37%% | |||||||||||||||||||||||||||||||||||||||||||||||||
In the Infibeam IPO retail investors (RII) are offered 12,50,000 shares while in Thyrocare Technologies IPO retail investors are offered 12,50,000 shares. Qualified institutional buyers (QIB) are offered 93,75,000 shares in Infibeam IPO and 21,48,942 shares in Thyrocare Technologies IPO.
| Infibeam IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 93,75,000 shares | 21,48,942 shares |
| NII | 18,75,000 shares | 16,11,707 shares |
| RII | 12,50,000 shares | 37,60,648 shares |
| Employee | ||
| Others | ||
| Total | 1,25,00,000 shares | 75,21,297 shares |
Infibeam IPO subscribed 1.11x in total, whereas Thyrocare Technologies IPO subscribed 73.55x.
| Infibeam IPO | Thyrocare Technologies IPO | |
|---|---|---|
| QIB (times) | 0.86x | 73.18x |
| NII (times) | 2.23x | 225.30x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.31x | 8.73x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.11x | 73.55x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
